- How the BMTCN Blueprint Is Built
- Domain 1: Foundations of HSCT and Cellular Therapy
- Domain 2: HSCT and Cellular Therapy Process and Administration
- Domain 3: Post-HSCT Management and Education
- Domain 4: Post-Cellular Therapy Management and Education
- Domain 5: Quality of Life
- Domain 6: Professional Performance
- Domain Weight at a Glance
- How Domains Show Up in the Question Format
- Mapping a Study Timeline to the Domains
- FAQ
- Four domains - Foundations, Process/Administration, Post-HSCT Management, and Post-Cellular Therapy Management - are tied at 22% each.
- Quality of Life (8%) and Professional Performance (4%) are smaller but still scored on every exam attempt.
- The blueprint reflects the 2024 role delineation study, so older domain breakdowns no longer apply.
- The exam delivers 165 multiple-choice questions in 3 hours: 125 scored plus 40 unscored pretest items mixed throughout.
How the BMTCN Blueprint Is Built
The Blood and Marrow Transplant Certified Nurse exam is organized around six content domains derived from a 2024 role delineation study - a structured job analysis that asks practicing HSCT and cellular therapy nurses what they actually do, how often, and how critically. That study is why the current blueprint looks different from older breakdowns you might find in outdated study materials. If you're comparing sources, make sure anything you use reflects this current structure, not a legacy version.
Rather than one dominant domain, the blueprint splits the bulk of the exam almost evenly across four large content areas, each weighted at 22%. Two smaller domains - Quality of Life and Professional Performance - round out the remaining content. Understanding this weighting matters because it tells you where to spend your limited study hours. For a broader walkthrough of how to convert this blueprint into an actual study plan, see the BMTCN Study Guide 2026: How to Pass on Your First Attempt.
Domain 1: Foundations of HSCT and Cellular Therapy (22%)
This domain covers the groundwork every transplant and cellular therapy nurse needs before a patient ever reaches the infusion chair. Expect questions on the underlying science and clinical decision-making that determine which patients are candidates for HSCT or cellular therapy, and which approach fits their disease and status.
Foundations of HSCT and Cellular Therapy
Candidates must understand the biological and clinical reasoning behind transplant and cellular therapy decisions, not just terminology.
- Indications for autologous, allogeneic, and cellular therapy approaches across disease states
- Donor selection principles, HLA matching concepts, and graft source considerations
- Conditioning regimen intensity and how it shapes toxicity risk and nursing surveillance
- Pre-transplant workup, organ function assessment, and patient/family education prior to admission
Domain 2: HSCT and Cellular Therapy Process and Administration (22%)
Domain 2 shifts from "why" to "how." This is the operational core of transplant nursing - the mechanics of collecting, processing, and administering stem cell and cellular therapy products safely.
Process and Administration
This domain tests hands-on procedural knowledge tied to product handling and infusion safety.
- Stem cell collection, mobilization protocols, and apheresis basics
- Product identification, verification, and chain-of-custody safeguards before infusion
- Infusion-related reactions and immediate nursing interventions during administration
- Cellular therapy manufacturing timelines and how they affect scheduling and patient readiness
Because this domain is procedure-heavy, questions often present a clinical scenario and ask you to sequence the correct nursing action. Reviewing step-by-step protocols alongside rationale - not just memorizing lists - pays off here.
Domain 3: Post-HSCT Management and Education (22%)
Once a transplant is complete, the nursing focus moves to engraftment monitoring, complication recognition, and long-term recovery education. This domain leans heavily on pattern recognition: knowing which symptoms point to graft-versus-host disease, infection, veno-occlusive disease, or other transplant-specific complications, and how urgently each requires intervention.
Post-HSCT Management and Education
- Engraftment timelines and expected versus concerning lab trends
- Recognition and grading concepts for acute and chronic graft-versus-host disease
- Infection prevention and management during neutropenic and immunosuppressed phases
- Discharge planning, caregiver education, and long-term follow-up expectations
Key Takeaway
Domains 3 and 4 both use the word "Management and Education," but they apply to different patient populations - HSCT recipients versus cellular therapy recipients. Don't blur the two when building flashcards; keep complication profiles separated by treatment type.
Domain 4: Post-Cellular Therapy Management and Education (22%)
Cellular therapy - including CAR T-cell and other engineered cell products - carries its own distinct toxicity profile and monitoring requirements, separate from traditional transplant. This domain isolates that knowledge so it can't get lost inside general HSCT content.
Post-Cellular Therapy Management and Education
- Cytokine release syndrome recognition, grading logic, and escalation pathways
- Neurotoxicity monitoring and assessment tools specific to cellular therapy patients
- Timing windows for toxicity onset that differ from classic transplant complications
- Patient and caregiver education tailored to cellular therapy discharge criteria
Because Domains 3 and 4 together account for 44% of the exam, mastering complication management across both transplant and cellular therapy populations is arguably the single highest-leverage thing you can do to prepare. If you want a deeper breakdown of how difficult this content actually is to master under exam conditions, read How Hard Is the BMTCN Exam? Complete Difficulty Guide 2026.
Domain 5: Quality of Life (8%)
Quality of Life is smaller in weight but broad in scope. It covers the psychosocial, symptom-management, and survivorship dimensions of transplant and cellular therapy care that extend well beyond the acute clinical episode.
Quality of Life
- Symptom burden management, including fatigue, pain, and nutritional concerns
- Psychosocial support for patients and families across the treatment trajectory
- Survivorship issues and late effects that surface months or years post-treatment
- Resources and referrals nurses use to support long-term recovery
Domain 6: Professional Performance (4%)
The smallest domain, Professional Performance, still appears on every exam form. It addresses the nurse's role as a professional within the transplant and cellular therapy care team.
Professional Performance
- Evidence-based practice application in specialized transplant settings
- Interdisciplinary collaboration and care coordination responsibilities
- Ethical and legal considerations specific to transplant and cellular therapy nursing
- Patient advocacy and informed consent processes for high-risk procedures
Because this domain carries only 4% weight, it should get proportionally light study time - a focused review pass rather than a dedicated multi-day block.
Domain Weight at a Glance
| Domain | Weight |
|---|---|
| Foundations of HSCT and Cellular Therapy | 22% |
| HSCT and Cellular Therapy Process and Administration | 22% |
| Post-HSCT Management and Education | 22% |
| Post-Cellular Therapy Management and Education | 22% |
| Quality of Life | 8% |
| Professional Performance | 4% |
For the full mechanics of what score you need after answering these questions, see BMTCN Passing Score 2026: Exactly What You Need to Pass.
How Domains Show Up in the Question Format
The exam consists of 165 multiple-choice questions delivered in a single 3-hour session. Of those, 125 are scored and 40 are unscored pretest items being evaluated for future exam forms - but they're mixed in throughout, so you won't know which is which while testing. That means every question deserves full attention regardless of domain.
Each question is tagged to one of the six domains behind the scenes, which is how ONCC ensures the final scaled score (55 on a 25-75 scale to pass) reflects the intended weighting. A candidate who is strong in Domain 1 but weak across Domains 3 and 4 will feel the gap, since those two post-treatment domains combined make up nearly half the exam.
Mapping a Study Timeline to the Domains
A domain-weighted study plan is more efficient than an evenly divided one. Since four domains each carry 22%, and Domains 3 and 4 involve complication recognition that takes longer to internalize than definitions, front-load your calendar accordingly rather than splitting time equally across all six.
Foundations and Process
- Cover Domain 1 concepts: indications, donor selection, conditioning regimens
- Move into Domain 2: collection, product verification, infusion administration
Post-HSCT Complications
- Drill engraftment timelines and GVHD recognition patterns under Domain 3
- Use scenario-based practice questions to test sequencing of nursing actions
Post-Cellular Therapy Complications
- Separate cytokine release syndrome and neurotoxicity grading under Domain 4
- Compare onset timing against Domain 3 complications to avoid mixing them up
Quality of Life, Professional Performance, and Full Review
- Light review of Domains 5 and 6 given their smaller weight
- Full-length timed practice run on the practice test platform to simulate the 3-hour session
This structure is a starting point, not a rigid rulebook - adjust it based on your own clinical background using the more detailed week-by-week plan in the BMTCN Study Guide 2026: How to Pass on Your First Attempt.
Who Relies on This Domain Structure
Transplant units, cellular therapy programs, and stem cell processing centers reference this domain structure when evaluating candidates for HSCT and cellular therapy nursing roles, since it maps directly to the day-to-day competencies those units need. If you're weighing whether earning this credential translates into better job opportunities, compare the domain content against real listings in BMTCN Jobs, and see the broader career case in Is the BMTCN Certification Worth It? Complete ROI Analysis 2026. For salary context tied to this certification, review the BMTCN Salary Guide 2026: Complete Earnings Analysis.
It's also worth noting that ONCC has renamed this credential the Transplantation and Cellular Therapy Certified Nurse (TCTCN), effective January 1, 2026, with exams delivered through PSI. The domain content and structure described here reflect the current blueprint under this transition, so double-check which name a resource uses before trusting its details.
Turning Domain Knowledge Into Exam-Day Readiness
Knowing the six domains by name is only step one. The real test is whether you can apply that knowledge under timed, scenario-based conditions across all 165 questions. Practicing with domain-tagged question banks lets you see exactly where your weak spots sit relative to the 22/22/22/22/8/4 split, rather than guessing based on how confident you feel in general.
Run timed sets through a full practice test to build stamina for the 3-hour format, then review your results by domain rather than just by overall score. If Domain 4 questions are consistently missed, that's a targeted fix - not a reason to restart your entire study plan. For a data-informed look at how candidates typically perform, see BMTCN Pass Rate 2026: What the Data Shows, and for a condensed reference you can review right before test day, bookmark the BMTCN Cheat Sheet 2026: One-Page Review of Must-Know Facts.
FAQ
Four domains are tied for the largest weight at 22% each: Foundations of HSCT and Cellular Therapy, HSCT and Cellular Therapy Process and Administration, Post-HSCT Management and Education, and Post-Cellular Therapy Management and Education.
ONCC doesn't publish an exact question count per domain, but the exam totals 165 multiple-choice questions - 125 scored and 40 unscored pretest items - distributed according to the published domain weights.
No. At 8% of the exam, Quality of Life still represents a meaningful share of scored questions and covers symptom management, psychosocial support, and survivorship topics that deserve dedicated review time.
They address different patient populations. Domain 3 focuses on post-HSCT complications like graft-versus-host disease, while Domain 4 focuses on post-cellular therapy issues like cytokine release syndrome and neurotoxicity.
Requirements include an active RN license, two years of RN experience within the previous four years, 2,000 hours of HSCT or cellular-therapy nursing within four years, and 10 contact hours within three years - detailed fully in BMTCN Requirements 2026: Eligibility, Prerequisites & How to Qualify.